Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology)

Although the evidence for the benefit of adding temozolomide (TMZ) to radiotherapy (RT) is limited to glioblastoma patients, there is currently a trend toward treating anaplastic astrocytomas (AAs) with combined RT + TMZ. The aim of the present study was to describe the patterns of care of patients...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Scoccianti, Silvia, Magrini, Stefano Maria, Ricardi, Umberto, Detti, Beatrice, Krengli, Marco, Parisi, Salvatore, Bertoni, Filippo, Sotti, Guido, Cipressi, Samantha, Tombolini, Vincenzo, Dall'Oglio, Stefano, Lioce, Marco, Saieva, Calogero, Buglione, Michela, Mantovani, Cristina, Rubino, Giovanni, Muto, Paolo, Fusco, Vincenzo, Fariselli, Laura, de Renzis, Costantino, Masini, Laura, Santoni, Riccardo, Pirtoli, Luigi, Biti, Giampaolo
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2012
Θέματα:
Clinical Investigations
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3367850/
https://ncbi.nlm.nih.gov/pubmed/22539339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos081
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια